PBX1 and acute lymphoblastic leukemia: This technical approach was used to systematically create specific depletions of targeted transcripts in human E2A-PBX1+ ALL RCH-ACV cell line, which were then evaluated for effects on sustained proliferation (enhanced or suppressed) over time (Fig. 1A).